Considering that curcumin treated cells were actively transiting through mitosis before undergoing mitotic catastrophe, it further implies that inducing CUGBP2 and TIA-1 might be an effective chemotherapeutic strategy to treat pancreatic cancer cells. The gene discussed is CELF2; the disease is familial pancreatic carcinoma.